PRESS RELEASE published on 03/27/2025 at 23:12, 9 months 24 days ago Prospect Ridge Announces Resignation of President and Director Prospect Ridge Resources Corp. announces Mr. Yan Ducharme's resignation as President and Director, with Len Brownlie assuming the President role. Mike Iverson expresses gratitude for Yan's contribution and highlights exploration plans at Holy Grail and Knauss Creek projects Exploration Projects Management Changes Prospect Ridge Resources Corp. President Resignation Future Endeavors
PRESS RELEASE published on 03/27/2025 at 22:40, 9 months 24 days ago STMicroelectronics Reports on Resolutions to be Proposed at the 2025 Annual General Meeting of Shareholders STMicroelectronics announces proposed resolutions for the 2025 Annual General Meeting of Shareholders, including dividend distribution and board appointments Dividend Distribution Resolutions Board Appointments STMicroelectronics 2025 AGM
PRESS RELEASE published on 03/27/2025 at 22:15, 9 months 24 days ago Interactive Strength Inc. (Nasdaq:TRNR)'s FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX Interactive Strength Inc. announces exclusive partnership with Virgin Atlantic, featuring FORME Studio in Clubhouse at LAX. Partnership enhances wellness experience for travelers Interactive Strength Inc. Virgin Atlantic FORME Studio Premium Hospitality Wellness Partner
PRESS RELEASE published on 03/27/2025 at 21:18, 9 months 24 days ago Inside Information / Other news releases Veolia Environnement announces availability of 2024 Universal Registration Document and Annual Financial Report in English. Hard copies in French also available Annual Financial Report 2024 Universal Registration Document Veolia Environnement English Version
PRESS RELEASE published on 03/27/2025 at 21:15, 9 months 24 days ago Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC Nanobiotix announces first data from the completed dose escalation part of a Phase 1 study evaluating NBTXR3 (JNJ-1900) as a 2L+ therapy for patients with locally advanced NSCLC. The study shows favorable safety and injection feasibility, with promising survival data NSCLC NANOBIOTIX NBTXR3 Phase 1 Study Dose Escalation
PRESS RELEASE published on 03/27/2025 at 21:13, 9 months 24 days ago EQS-Adhoc: Basler AG: Basler publishes audited financial statements for the 2024 financial year, including a forecast for 2025 and a medium-term outlook Basler AG publishes audited financial statements for 2024 with a forecast for 2025 and a medium-term outlook, revealing sales of Euro 183.7 million and EBITDA of Euro 10.0 million Sales Forecast 2024 Basler AG Audited Financial Statements
PRESS RELEASE published on 03/27/2025 at 21:05, 9 months 24 days ago CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE CureVac receives positive validity decision from European Patent Office in litigation against BioNTech SE regarding mRNA patent BioNTech SE CureVac Patent Litigation European Patent Office MRNA Patent
PRESS RELEASE published on 03/27/2025 at 20:07, 9 months 24 days ago EQS-Adhoc: MBB SE proposes 15th consecutive base dividend increase to €1.11 and anniversary dividend of €2.22 MBB SE proposes 15th consecutive base dividend increase to €1.11 and anniversary dividend of €2.22. Total dividend of €3.33 per share. Annual Report 2024 to be published on 31 March 2025 Shareholders Special Dividend Dividend Increase Annual Report MBB SE
PRESS RELEASE published on 03/27/2025 at 20:00, 9 months 24 days ago Amaze Partners with Empact to Unlock $707.9B EU E-Commerce Market for Creators, Eliminating Surprise Fees and Expanding Global Reach Amaze partners with Empact to enhance creator-fan shopping experience in EU. Collaboration tackles high shipping costs and delivers transparent pricing, faster delivery, and VAT compliance Partnership EU Amaze Empact Creator-fan Shopping Experience
PRESS RELEASE published on 03/27/2025 at 19:26, 9 months 24 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 15,000 'A' ordinary shares as part of its share buyback program on 27/03/2025. Highest price paid: 537.00 GBp, Lowest price: 534.00 GBp London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited 'A' Ordinary Shares
Published on 01/21/2026 at 08:05, 15 minutes ago Tocvan Provides Gran Pilar Gold-Silver Project Update Advancing Pilot Mine Development and Drilling on South Block
Published on 01/21/2026 at 08:00, 20 minutes ago Sintana Energy Inc. Provides Portfolio Update - Walvis Basin Expansion
Published on 01/21/2026 at 00:30, 7 hours 50 minutes ago Caledonia Announces Closing of Upsized $150 Million Convertible Senior Notes Offering and Full Exercise of Initial Purchasers' Option to Purchase Additional Notes
Published on 01/20/2026 at 23:35, 8 hours 45 minutes ago Further Shallow High-Grade Assays Infill Tunkillia S1/2 Pits
Published on 01/20/2026 at 23:30, 8 hours 50 minutes ago Correction to Press Release Issued on January 16, 2026 Announcing Closing of $976,000 Non-Brokered Private Placement
Published on 01/21/2026 at 08:05, 14 minutes ago Hyundai Mobis Embeds 5G Wireless Telematics Technology for Autonomous and SDV Vehicles
Published on 01/20/2026 at 17:59, 14 hours 20 minutes ago Statement of transactions in own shares from January 14, 2026 to January 16, 2026
Published on 01/20/2026 at 07:30, 1 day ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:35, 1 day 14 hours ago EURAZEO ENTERS INTO AN EXCLUSIVE AGREEMENT WITH L CATTERTON FOR THE SALE OF ITS MINORITY STAKE IN EX NIHILO